http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611398-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7db2b5799ccb0dc6ecda321c5c107fce |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
| filingDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b973c07d87fb5fc4723f5cc1e516a499 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0886987e8f53a67e60c21a06919debf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85aecd24ef034c3ca4a620a703c23cb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e47f2497cdb1cfe0fa876ecaae5985e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6fd56e068a03dd2d144c924a5982cc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcba0e657827bf1fe7b87823147657e6 |
| publicationDate | 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2611398-C1 |
| titleOfInvention | Method of increasing the efficiency of treatment of patients with tuberculosis |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to phthisiology, and can be used to improve the efficiency of treatment of patients with tuberculosis. Method includes the determination of the degree of patient’s medication adherence through his questioning, which is performed at the beginning of the main course of treatment. Stens are determined and after its determination diagnose the factors affecting the level of adherence, and then the prediction of medication adherence is determined: if total score is from 35 points and more, 1–2 stens mark the unsatisfactory medication adherence, if it is 16–34 points, 3–5 stens mark satisfactory medication adherence, if it is 4–15 points, 6–8 stens mark good medication adherence, if it is up to 3 points, 9–10 stens mark medication adherence. In case of unfavorable prognosis at 1–5 stens prescribe cycloferon immunomodulator and methods of psychotherapy, as well as the chemotherapy regimen correction is carried out by changing the method of administration of etiotropic drugs, and at a satisfactory medication adherence etiotropic drugs are administered parenterally, and at unsatisfactory medication adherence etiotropic drugs are administered parenterally and inhalationly. n EFFECT: use of invention improves efficiency of treatment of patients with tuberculosis by determining the degree of patient’s medication adherence for further treatment correction. n 1 cl, 2 ex |
| priorityDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.